Loading insider details...
Beta
Latest Form 4 (Mar 13, 2024): Grant/Award of 23,205 MOTS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 13, 2024 | Motus GI Holdings, Inc. (MOTS) | Grant/Award | 23,205 | n/a |
| Mar 7, 2024 | Ambrx Biopharma, Inc. (AMAM) | Disposition to Issuer | 22,936 | n/a |
| Jan 13, 2021 | NantKwest, Inc. (NK) | Exercise/Conversion | 11,364 | $34.9K |
| Jan 6, 2021 | NantKwest, Inc. (NK) | Exercise/Conversion | 22,729 | $69.8K |
| Aug 4, 2020 | NantKwest, Inc. (NK) | Exercise/Conversion | 10,000 | n/a |
| Mar 24, 2020 | NantKwest, Inc. (NK) | Exercise/Conversion | 15,000 | n/a |